Sector consensus Cardiol Therapeutics Inc.

Stocks

Market Closed - Toronto S.E. 21:00:00 18/08/2026 BST			5-day change	1st Jan Change
2.610 ^CAD	+4.82%		+23.70%	+99.24%

08-12	Cardiol Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Cardiol Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
CARDIOL THERAPEUTICS INC.	6	+140.96%	2
LONZA GROUP AG	681.13	+20.26%	23
REVOLUTION MEDICINES, INC.	221.9	+4.67%	21
BEONE MEDICINES AG	433.02	+19.45%	27
IQVIA HOLDINGS INC.	275.17	+14.06%	18
CELLTRION, INC.	264,708.89	+31.7%	24
MEDPACE HOLDINGS, INC.	581.83	-2.56%	12
ASCENDIS PHARMA A/S	268.07	+25.51%	18
EUROFINS SCIENTIFIC SE	72.53	+3.61%	14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	281	-1.97%	14
ICON PUBLIC LIMITED COMPANY	185.56	+9.51%	16
PHARMARON BEIJING CO., LTD.	38.15	-23.87%	11
BIO-TECHNE CORPORATION	70.73	-2.3%	11
ABIVAX	138.97	+31.23%	6
PRAXIS PRECISION MEDICINES, INC.	633.16	+68.22%	19
PROTAGONIST THERAPEUTICS, INC.	170.38	+7.42%	13
APOGEE THERAPEUTICS, INC.	134.85	+0.19%	11
KYMERA THERAPEUTICS, INC.	130.91	+7.82%	22
IONIS PHARMACEUTICALS, INC.	89.33	+52.37%	21
TEMPUS AI, INC.	62.64	+21.31%	14
Average	13,459.21	+21.38%	16
Weighted average by Cap.	23,237.71	+15.25%	19